Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December

Jan 04, 2021

|

NEW YORK – To round out the year, diagnostic firms, overall, saw higher gains in share prices during December as the 360Dx Index jumped 4 percent month over month, continuing November's upward trend.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December

To read the full story....

Breaking News

Drug Screen Lab Owner Sentenced to 36 Months in Prison

Qiagen MDx Sample Processing Platform Garners CE-IVD Mark

MDxHealth 2020 Revenues Up 57 Percent

Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings

Lumos Diagnostics Signs Canadian Distribution Deal for Acute Respiratory Infection Assay

Abbott SARS-CoV-2 IgG Antibody Test Receives Emergency Use Authorization from FDA

What's Popular?

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings

Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

Sponsorships